Up a level |
De Francesco, Davide, Wang, Xinzhu, Dickinson, Laura ORCID: 0000-0001-5557-9396, Underwood, Jonathan, Bagkeris, Emmanouil, Babalis, Daphne S, Mallon, Patrick WG, Post, Frank A, Vera, Jaime H, Sachikonye, Memory et al (show 5 more authors)
(2021)
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.
PLOS ONE, 16 (7).
e0253861-.
Waters, Laura, Winston, Alan, Reeves, Iain, Boffito, Marta, Churchill, Duncan, Cromarty, Ben, Dunn, David, Fink, Douglas, Fidler, Sarah, Foster, Caroline et al (show 14 more authors)
(2022)
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
HIV MEDICINE, 23 (S5).
pp. 3-115.
Churchill, Duncan, Waters, Laura, Ahmed, Nadia, Angus, Brian, Boffito, Marta, Bower, Mark, Dunn, David, Edwards, Simon, Emerson, Carol, Fidler, Sarah et al (show 21 more authors)
(2016)
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
HIV MEDICINE, 17 (S4).
S2-S104.
Mora-Peris, Borja, Keegan, Michael R, Penchala, Sujan Dilly, Vera, Jaime H, Underwood, Jonathan, Khan, Maryam, Herrera, Carolina, Fuchs, Dietmar, Boasso, Adriano, Khoo, Saye ORCID: 0000-0002-2769-0967 et al (show 1 more authors)
(2021)
Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial.
HIV RESEARCH & CLINICAL PRACTICE, 22 (6).
pp. 151-159.
Winston, Alan, Amin, Janaki, Clarke, Amanda, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Owen, Andrew ORCID: 0000-0002-9819-7651, Barber, Tristan, Jessen, Heiko, Avinghsanon, Anchalee, Chetchotisakd, Ploenchan et al (show 4 more authors)
(2015)
Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial.
CLINICAL INFECTIOUS DISEASES, 60 (7).
pp. 1026-1032.
Seden, Kay, Gibbons, Sara, Marzolini, Catia, Schapiro, Jonathan M, Burger, David M, Back, David J and Khoo, Saye H ORCID: 0000-0002-2769-0967
(2017)
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.
PLOS ONE, 12 (3).
e0173509-.
Wang, Xinzhu, Boffito, Marta, Dickinson, Laura ORCID: 0000-0001-5557-9396, Bagkeris, Emmanouil, Khoo, Saye ORCID: 0000-0002-2769-0967, Post, Frank A, Vera, Jaime, Williams, Ian, Ndoutoumou, Amalia, Anderson, Jane et al (show 5 more authors)
(2020)
Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV.
AIDS, 34 (5).
pp. 790-793.
Wang, Xinzhu, Boffito, Marta, Dickinson, Laura ORCID: 0000-0001-5557-9396, Bagkeris, Emmanouil, Khoo, Saye, Post, Frank A, Vera, Jaime, Williams, Ian, Ndoutoumou, Amalia, Anderson, Jane et al (show 5 more authors)
(2020)
Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIV.
AIDS, 34 (5).
pp. 790-793.
Dickinson, Laura ORCID: 0000-0001-5557-9396, Winston, Alan, Boffito, Marta, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2016)
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approach.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (4).
pp. 1041-1045.
Penchala, Sujan Dilly, Alagaratnam, Jasmini, Challenger, Elizabeth ORCID: 0000-0002-8978-6067, Amara, Alieu ORCID: 0000-0002-1137-2948, Else, Laura, Winston, Alan and Khoo, Saye ORCID: 0000-0002-2769-0967
(2020)
The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
BIOMEDICAL CHROMATOGRAPHY, 34 (1).
e4711-.
Quinn, Killian, Traboni, Cinzia, Penchala, Sujan Dily, Bouliotis, Georgios, Doyle, Nicki, Libri, Vincenzo, Khoo, Saye ORCID: 0000-0002-2769-0967, Ashby, Deborah, Weber, Jonathan, Nicosia, Alfredo et al (show 3 more authors)
(2017)
A first-in-human study of the novel HIV-fusion inhibitor C34-PEG<sub>4</sub>-Chol.
SCIENTIFIC REPORTS, 7 (1).
9447-.